Anthony Barron is the keynote presenter and author of the study being discussed during the event.
For more information on this event, click here.
Government Scorekeepers Likely Underestimate the Impact of Lower Drug Costs Now Act (H.R.3) on Investment in Innovative Medicines: Brief
In 2020, the US House of Representatives passed the “Lower Drug Costs Now Act” (H.R.3), which would require the federal government to set the price of many...